A new treatment option for pancreatic cancer patients, using electric field-generating devices by Novocure and Zai Lab, shows promising results in increasing survival rates. With FDA approvals for lung cancer treatment, Novocure's stock is on the rise, hinting at a profitable future.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing